4Ahrendt SA, Yang SC, Wu L, et al. Molecular assessment of lymph nodes in patients with resected stage Ⅰ non-small cell lung cancer: preliminary results of a prospective study. J Thorac Cardiovasc Surg,2002,123(3) : 466-474.
5Tajima K, Obata Y, Tamaki H, et al. Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer,2003,42(1) : 23-33.
6Fukagawa T, Sasako M, Mann GB, et al. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer,2001,92(4): 753-760.
7Park JW, Kwon TK, Kim IH, et al. A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods,2002,266(1-2).
8Mitas M, Cole DJ, Hoover L, et al. Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem,2003,49(2) :312-315.
9Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resec-ted nonsmall cell lung cancer: impact on recurrence and Survival.Ann Surg,2002,235(1): 133-139.
8Dobashi K, Sugio K, Osaki T, et al. Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer:prognostic significance. J Thorac Cardiovasc Surg, 1997,114:339-345.
9Mountain CF. Revisions in the international system for staging of lung cancer. Chest,1997,111(7) :1710-1717.
10Dowlatshahi K,Fan M,Bloom KJ,et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. Cancer, 1999,86(6) :990-996.
